DK3880676T3 - 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer - Google Patents

2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer Download PDF

Info

Publication number
DK3880676T3
DK3880676T3 DK19813943.8T DK19813943T DK3880676T3 DK 3880676 T3 DK3880676 T3 DK 3880676T3 DK 19813943 T DK19813943 T DK 19813943T DK 3880676 T3 DK3880676 T3 DK 3880676T3
Authority
DK
Denmark
Prior art keywords
pyrrolo
pyridin
dihydro
cancer
derivatives
Prior art date
Application number
DK19813943.8T
Other languages
English (en)
Inventor
Rebecca Anne Gallego
Sajiv Krishnan Nair
Robert Steven Kania
Omar Khaled Ahmad
Ted William Johnson
Jamison Bryce Tuttle
Mehran Jalaie
Michele Ann Mctigue
Dahui Zhou
Bel Matthew L Del
Ru Zhou
Mingying He
Anne-Marie Dechert Schmitt
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68771726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3880676(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK3880676T3 publication Critical patent/DK3880676T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK19813943.8T 2018-11-15 2019-11-12 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer DK3880676T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862767602P 2018-11-15 2018-11-15
US201962909970P 2019-10-03 2019-10-03
PCT/IB2019/059702 WO2020100027A1 (en) 2018-11-15 2019-11-12 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer

Publications (1)

Publication Number Publication Date
DK3880676T3 true DK3880676T3 (da) 2023-09-04

Family

ID=68771726

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19813943.8T DK3880676T3 (da) 2018-11-15 2019-11-12 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer

Country Status (38)

Country Link
US (1) US11142525B2 (da)
EP (1) EP3880676B1 (da)
JP (1) JP7118267B2 (da)
KR (1) KR20210090675A (da)
CN (1) CN113316576A (da)
AU (1) AU2019378184B2 (da)
BR (1) BR112021008991A2 (da)
CA (1) CA3061392A1 (da)
CL (1) CL2021001190A1 (da)
CO (1) CO2021006114A2 (da)
CR (1) CR20210251A (da)
CU (1) CU20210035A7 (da)
CY (1) CY1126663T1 (da)
DK (1) DK3880676T3 (da)
DO (1) DOP2021000088A (da)
EC (1) ECSP21034668A (da)
ES (1) ES2958948T3 (da)
FI (1) FI3880676T3 (da)
GE (2) GEP20227434B (da)
HR (1) HRP20231089T1 (da)
HU (1) HUE063367T2 (da)
IL (1) IL283149A (da)
LT (1) LT3880676T (da)
MD (1) MD3880676T2 (da)
MX (1) MX2021005754A (da)
PE (1) PE20211868A1 (da)
PH (1) PH12021551117A1 (da)
PL (1) PL3880676T3 (da)
PT (1) PT3880676T (da)
PY (1) PY1996328A (da)
RS (1) RS64655B1 (da)
SG (1) SG11202104394XA (da)
SI (1) SI3880676T1 (da)
TW (1) TWI718758B (da)
UA (1) UA127426C2 (da)
UY (1) UY38471A (da)
WO (1) WO2020100027A1 (da)
ZA (1) ZA202103099B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11203591B2 (en) 2018-10-31 2021-12-21 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds
WO2020092528A1 (en) 2018-10-31 2020-05-07 Gilead Sciences, Inc. Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity
EP3972695A1 (en) 2019-05-23 2022-03-30 Gilead Sciences, Inc. Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
MX2022002877A (es) * 2019-09-13 2022-08-08 Nimbus Saturn Inc Antagonistas de cinasa progenitora hematopoyetica 1 (hpk1) y sus usos.
PE20230323A1 (es) * 2020-05-01 2023-02-22 Pfizer Compuestos de azalactama como inhibidores de hpk1
CN112409268A (zh) * 2020-12-03 2021-02-26 西南交通大学 靶向Fam20C抑制剂的制备及其抗三阴性乳腺癌作用
US11926625B2 (en) * 2021-03-05 2024-03-12 Nimbus Saturn, Inc. HPK1 antagonists and uses thereof
WO2022213062A1 (en) 2021-03-29 2022-10-06 Nimbus Saturn, Inc. Hpk1 antagonists and uses thereof
WO2022258044A1 (zh) * 2021-06-11 2022-12-15 杭州中美华东制药有限公司 吡咯并吡啶酮类化合物及其制备方法和用途
TW202321239A (zh) 2021-07-20 2023-06-01 瑞典商阿斯特捷利康公司 作為ｈｐｋ１抑制劑用於治療癌症之經取代的吡𠯤—２—甲醯胺
WO2023015199A1 (en) * 2021-08-03 2023-02-09 Nimbus Saturn, Inc. Hpk1 antagonists and uses thereof
WO2023023942A1 (en) * 2021-08-24 2023-03-02 Biofront Ltd (Cayman) Hpk1 inhibitors, compositions comprising hpk1 inhibitor, and methods of using the same
WO2023030478A1 (zh) * 2021-09-03 2023-03-09 浙江海正药业股份有限公司 吡啶并内酰胺类衍生物及其制备方法和用途
WO2023057883A1 (en) * 2021-10-05 2023-04-13 Pfizer Inc. Crystalline form of azalactam compound
CN114767676B (zh) 2022-04-22 2024-04-19 珠海宇繁生物科技有限责任公司 Hpk1激酶抑制剂在预防和/或治疗人的病原体感染中的应用
KR102855849B1 (ko) 2022-11-25 2025-09-08 충남대학교산학협력단 이미다조피리딘 유도체, 이를 유효성분으로 포함하는 약제학적 조성물 및 이를 이용하는 암의 치료 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
MY150032A (en) * 2007-07-19 2013-11-29 Merck Sharp & Dohme Heterocyclic amide compounds as protein kinase inhibitors
JP7086942B2 (ja) 2016-09-12 2022-06-20 インテグラル ヘルス， インコーポレイテッド Ｇｐｒ１２０モジュレーターとして有用な単環式化合物
CN110402248B (zh) 2017-03-15 2023-01-06 豪夫迈·罗氏有限公司 作为hpk1抑制剂的氮杂吲哚类
TW201908306A (zh) 2017-07-18 2019-03-01 大陸商南京聖和藥業股份有限公司 作為ask抑制劑的雜環化合物及其應用
EP3743063A4 (en) 2018-01-26 2021-10-20 Nurix Therapeutics, Inc. CBL-B INHIBITORS AND THEIR METHODS OF USE

Also Published As

Publication number Publication date
PY1996328A (es) 2021-05-21
HUE063367T2 (hu) 2024-01-28
RS64655B1 (sr) 2023-10-31
CN113316576A (zh) 2021-08-27
WO2020100027A1 (en) 2020-05-22
BR112021008991A2 (pt) 2021-08-10
GEAP202215630A (en) 2022-06-27
JP7118267B2 (ja) 2022-08-15
HRP20231089T1 (hr) 2023-12-22
UY38471A (es) 2020-06-30
KR20210090675A (ko) 2021-07-20
CY1126663T1 (el) 2026-02-25
AU2019378184A1 (en) 2021-05-27
JP2022507231A (ja) 2022-01-18
ES2958948T3 (es) 2024-02-16
CR20210251A (es) 2021-07-14
SI3880676T1 (sl) 2023-10-30
CA3061392A1 (en) 2020-05-15
PH12021551117A1 (en) 2021-11-22
AU2019378184B2 (en) 2022-09-15
MX2021005754A (es) 2021-08-11
FI3880676T3 (fi) 2023-09-15
ZA202103099B (en) 2023-11-29
US11142525B2 (en) 2021-10-12
EP3880676A1 (en) 2021-09-22
GEP20227434B (en) 2022-10-25
UA127426C2 (uk) 2023-08-16
DOP2021000088A (es) 2021-06-30
SG11202104394XA (en) 2021-05-28
EP3880676B1 (en) 2023-08-02
PL3880676T3 (pl) 2023-12-11
CU20210035A7 (es) 2021-12-08
LT3880676T (lt) 2023-09-25
CO2021006114A2 (es) 2021-05-31
TWI718758B (zh) 2021-02-11
PE20211868A1 (es) 2021-09-21
MD3880676T2 (ro) 2023-12-31
IL283149A (en) 2021-06-30
ECSP21034668A (es) 2021-06-30
PT3880676T (pt) 2023-10-04
CL2021001190A1 (es) 2021-12-24
TW202031657A (zh) 2020-09-01
US20200172539A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
DK3880676T3 (da) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer
DK3523301T3 (da) Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer
DK3523302T3 (da) Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer
DK3873903T3 (da) Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere
CO2018008761A2 (es) Derivados de maitansinoide, conjugados de los mismos métodos de uso
WO2017108723A3 (en) PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
DK3672975T3 (da) Kondenserede, heterocykliske derivater som bcl-2-hæmmere til behandling af neoplastiske sygdomme
MA52987A (fr) Dérivés de pyrazolo[1,5-a]pyrazin-4-yl en tant qu'inhibiteurs de jak
MA41251A (fr) Dérivés de thiéno[2,3-c]pyrrol-4-one comme inhibiteurs erk
EA201791692A1 (ru) 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ
IL261015A (en) History of methylamine as lysis oxidase inhibitors for cancer treatment
MX2022007436A (es) Inhibidores de la autotaxina y sus usos.
DK3597649T3 (da) Sammensætninger indeholdende substituerede [1,2,4]triazolo[1,5-a]pyrimidin-7-yl-forbindelser som pde2-inhibitorer
BR112018005851A2 (pt) derivados de pirrolo[2,3-d]pirimidina como inibidores de dyrk1 / clk1 duais
EP3380475A4 (en) OCTAHYDROPYRROLO [3,4-C
DK3478681T3 (da) 1h-pyrazolo[4,3-b]pyridiner som pde1-inhibitorer
DK3380471T3 (da) Tetrahydro-8h-pyrido[1,2-a]pyrazin-8-oner som comt-inhibitorer til behandlingen af neurodegenerative lidelser
EP4650000A3 (en) High concentration formulation
EA201691412A1 (ru) Гидроксиформамидные производные и их применение
NI201800043A (es) Nuevos derivados de imidazo[4,5-b]piridina como inhibidores duales de dyrk1/clk1
DK3840832T3 (da) Imidazo[1,2-b]pyridaziner som trk-inhibitorer
DK4034122T3 (da) Fremgangsmåder til behandling af hyperfenylalaninæmi
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
DK3679042T3 (da) Imidazo[1,5-A]pyrazin-derivater som PI3Kdelta-inhibitorer
DK3083627T3 (da) [1,2,4]triazol[1,5-a]pyrimidinderivater som protozoiske proteasominhibitorer til behandling af parasitsygdomme, såsom leishmaniasis